Jared Firestone, J.D.

Jared Firestone, J.D., is a multi-disciplinary attorney with expertise in a range of legal areas. He founded and operated Firestone Law Firm PA in Hollywood, Florida, and worked as an Associate Attorney at Gustman Law P.C. in New York. His practice areas include Personal Injury, Criminal Defense, Medical Malpractice, Trusts & Wills, Civil and Commercial Litigation, Family Law, Real Estate, and Immigration. Additionally, he has experience in real estate, focusing on residential property in the Miami/Fort Lauderdale areas. Firestone also served as a pro bono Mediator at the Benjamin N. Cardozo School of Law Divorce Mediation Clinic. He holds a J.D. from Cardozo School of Law, where he honed skills in E-Discovery, Divorce Mediation, and Legal Writing, and a Bachelor’s degree in Philosophy from Tulane University.

Jared Firestone

Controversial Expert Testimony Survives Supreme Court Scrutiny In Oklahoma Death-Penalty Case

On June 29, 2015, the Supreme Court decided a controversial death-penalty case involving Oklahoma’s use of midazolam, a sedative, in its executions of prisoners. Finding that the use of the drug did not violate the Eighth Amendment’s ban on cruel and unusual punishment. The case was originally brought by four inmates set for death sentences

Posted on July 5, 2015 in News

Inferior Vena Cava Filters: What Litigators Need to Know

There are 23 lawsuits nationwide against inferior vena cava (IVC) filter manufacturer R.C. Bard that are seeking to consolidate in an MDL, with the Judicial Panel on Multidistrict Litigation debating the matter in an upcoming hearing session on July 30. The IVC filters are implanted in people in order to capture blood clots heading to

Posted on July 14, 2015 in News

5 New MDLs to Watch For

The U.S. Judicial Panel on Multidistrict Litigation (JPML) is scheduled to hear Oral Arguments for why cases on the following matters should be consolidated into one district. These hearings are scheduled for July 30, 2015 in San Francisco. 1. Bard IVC Filters products liability – MDL no. 2641 On May 18, 2015, plaintiffs in Bard

Posted on July 20, 2015 in News

Potential Class Action: Baby Powder Injuries

Two class-action lawsuits were filed against Johnson & Johnson in 2014 claiming that the company’s talcum powder products have been causing ovarian cancer in women. The two products the lawsuit cites are Johnson’s Baby Powder and Shower to Shower. One of the class-actions is being filed in California, and the other in Illinois. The class-actions

Posted on July 20, 2015 in News

Power Morcellator Class Action: Links Gynecological Procedure to Cancer Risk

The power morcellator class action investigation has emerged over the laparoscopic power morcellation used in many gynecological surgical procedures. The procedures include myomectomies, hysterectomies, oophorectomies, and salpingectomies. The laparoscopic power morcellators are used during these procedures to cut tissue and remove it. They are popular because they enable doctors to remove large specimens from the abdomen in a

Posted on July 27, 2015 in News

Eliquis Class Action: Another Blood Thinner to Spur a Class-Action Lawsuit

The Eliquis Class Action investigation has emerged against the blood thinner manufacturer.

Posted on July 27, 2015 in News

Artificial Turf Cancer Lawsuit: Toxic Compounds May be Linked to Cancer

Artificial turf, which has been installed at schools and athletic facilities around the country, has recently come under scrutiny as a potential source of cancer-causing toxins. Thus leading to an investigation which could result in a plethora of artificial turf cancer lawsuits.

Posted on August 3, 2015 in News

Car Hacking Class Action Takes Shape in California

A major breach in the digital security of many automobiles has allowed hackers to access critical systems and controls, posing a significant danger to the public. In response, a car hacking class action lawsuit has been filed on behalf of consumers in the U.S. District Court for the Northern District of California. The system in question

Posted on August 3, 2015 in News

Potential Onglyza Class Action Under Investigation

There is an ongoing class action investigation being conducted into Onglyza (saxagliptin). This is a drug that has been used to treat diabetes since 2009. Onglyza regulates blood sugar levels in those with diabetes. It has been linked to pancreatic cancer, thyroid cancer, and other dangerous side effects like heart failure. The drug amassed $820 million

Posted on August 6, 2015 in News

Depakote Class Action: Epilepsy Drug Investigated For Birth Defects

The Depakote class action has emerged recently, targeting the manufacturer’s anticonvulsant drug that has been prescribed to hundreds of thousands of Americans to treat epilepsy, bipolar mania, and migraines. The Depakote class action was filed in response to birth defects allegedly caused by exposure to Depakote in the womb. Including cardiovascular defects, brain defects, spina bifida

Posted on August 31, 2015 in News